These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33121321)

  • 21. Atomic level insights into realistic molecular models of dendrimer-drug complexes through MD simulations.
    Jain V; Maiti PK; Bharatam PV
    J Chem Phys; 2016 Sep; 145(12):124902. PubMed ID: 27782646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery.
    Luong D; Kesharwani P; Deshmukh R; Mohd Amin MCI; Gupta U; Greish K; Iyer AK
    Acta Biomater; 2016 Oct; 43():14-29. PubMed ID: 27422195
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Nazlı H; Gedik G
    Pharm Dev Technol; 2021 Sep; 26(7):750-764. PubMed ID: 34154500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
    Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
    Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective cytotoxicity of PAMAM G5 core--PAMAM G2.5 shell tecto-dendrimers on melanoma cells.
    Schilrreff P; Mundiña-Weilenmann C; Romero EL; Morilla MJ
    Int J Nanomedicine; 2012; 7():4121-33. PubMed ID: 22904625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene delivery efficiency and cytotoxicity of heterocyclic amine-modified PAMAM and PPI dendrimers.
    Hashemi M; Tabatabai SM; Parhiz H; Milanizadeh S; Amel Farzad S; Abnous K; Ramezani M
    Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():791-800. PubMed ID: 26838910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendrimers for Drug Delivery.
    Chauhan AS
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29670005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic studies of in vitro cytotoxicity of poly(amidoamine) dendrimers in mammalian cells.
    Mukherjee SP; Lyng FM; Garcia A; Davoren M; Byrne HJ
    Toxicol Appl Pharmacol; 2010 Nov; 248(3):259-68. PubMed ID: 20736030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide.
    Vandamme TF; Brobeck L
    J Control Release; 2005 Jan; 102(1):23-38. PubMed ID: 15653131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carboxymethyl chitosan-poly(amidoamine) dendrimer core-shell nanoparticles for intracellular lysozyme delivery.
    Zhang X; Zhao J; Wen Y; Zhu C; Yang J; Yao F
    Carbohydr Polym; 2013 Nov; 98(2):1326-34. PubMed ID: 24053810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partitioning of poly(amidoamine) dendrimers between n-octanol and water.
    Giri J; Diallo MS; Goddard WA; Dalleska NF; Fang X; Tang Y
    Environ Sci Technol; 2009 Jul; 43(13):5123-9. PubMed ID: 19673317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First evidences of PAMAM dendrimer internalization in microorganisms of environmental relevance: A linkage with toxicity and oxidative stress.
    Gonzalo S; Rodea-Palomares I; Leganés F; García-Calvo E; Rosal R; Fernández-Piñas F
    Nanotoxicology; 2015; 9(6):706-18. PubMed ID: 25325159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
    Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
    J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of generation on folic acid-modified poly(amidoamine) dendrimers for targeted delivery of baicalin to cancer cells.
    Lv T; Yu T; Fang Y; Zhang S; Jiang M; Zhang H; Zhang Y; Li Z; Chen H; Gao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():182-190. PubMed ID: 28415453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel dendrimer based on poly (L-glutamic acid) derivatives as an efficient and biocompatible gene delivery vector.
    Zeng X; Pan S; Li J; Wang C; Wen Y; Wu H; Wang C; Wu C; Feng M
    Nanotechnology; 2011 Sep; 22(37):375102. PubMed ID: 21852739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.
    Malik N; Wiwattanapatapee R; Klopsch R; Lorenz K; Frey H; Weener JW; Meijer EW; Paulus W; Duncan R
    J Control Release; 2000 Mar; 65(1-2):133-48. PubMed ID: 10699277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cationic PAMAM dendrimers disrupt key platelet functions.
    Jones CF; Campbell RA; Franks Z; Gibson CC; Thiagarajan G; Vieira-de-Abreu A; Sukavaneshvar S; Mohammad SF; Li DY; Ghandehari H; Weyrich AS; Brooks BD; Grainger DW
    Mol Pharm; 2012 Jun; 9(6):1599-611. PubMed ID: 22497592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of PEGylation and acetylation of PAMAM dendrimers on DNA binding, cytotoxicity and in vitro transfection efficiency.
    Fant K; Esbjörner EK; Jenkins A; Grossel MC; Lincoln P; Nordén B
    Mol Pharm; 2010 Oct; 7(5):1734-46. PubMed ID: 20695423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of the in vitro uptake mechanism and antioxidant levels in HaCaT cells and resultant changes to toxicity and oxidative stress of G4 and G6 poly(amidoamine) dendrimer nanoparticles.
    Maher MA; Byrne HJ
    Anal Bioanal Chem; 2016 Jul; 408(19):5295-307. PubMed ID: 27209595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CE of poly(amidoamine) succinamic acid dendrimers using a poly(vinyl alcohol)-coated capillary.
    Desai A; Shi X; Baker JR
    Electrophoresis; 2008 Jan; 29(2):510-5. PubMed ID: 18080252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.